Financial reports
10-Q
2019 Q3
Quarterly report
5 Nov 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
7 May 19
10-K
2018 FY
Annual report
26 Feb 19
10-Q
2018 Q3
Quarterly report
7 Nov 18
10-Q
2018 Q2
Quarterly report
6 Aug 18
10-Q
2018 Q1
Quarterly report
3 May 18
10-K
2017 FY
Annual report
22 Feb 18
10-Q
2017 Q3
Quarterly report
6 Nov 17
10-Q
2017 Q2
Quarterly report
7 Aug 17
Current reports
8-K
Completion of Acquisition or Disposition of Assets
20 Feb 20
8-K
Entry into a Material Definitive Agreement
10 Jan 20
8-K
Dermira Elects Halley E. Gilbert to its Board of Directors
13 Nov 19
8-K
Dermira Reports Third Quarter 2019 Financial Results and Provides Corporate Update
5 Nov 19
8-K
Other Events
9 Oct 19
8-K
Dermira Reports Second Quarter 2019 Financial Results and Provides Corporate Update
7 Aug 19
8-K
Other Events
25 Jun 19
8-K
Submission of Matters to a Vote of Security Holders
10 Jun 19
8-K
Dermira Reports First Quarter 2019 Financial Results
7 May 19
8-K
Dermira Prices $130.0 Million Public Offering of Common Stock
20 Mar 19
Registration and prospectus
15-12B
Securities registration termination
2 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 20
POSASR
Automatic shelf registration (post-effective amendment)
20 Feb 20
POS AM
Prospectus update (post-effective amendment)
20 Feb 20
SC 14D9/A
Tender offer solicitation (amended)
20 Feb 20
Proxies
Other
EFFECT
Notice of effectiveness
25 Feb 20
UPLOAD
Letter from SEC
28 Nov 18
EFFECT
Notice of effectiveness
23 Nov 18
CORRESP
Correspondence with SEC
19 Nov 18
CT ORDER
Confidential treatment order
19 Dec 17
CT ORDER
Confidential treatment order
22 Dec 16
EFFECT
Notice of effectiveness
24 Nov 15
CORRESP
Correspondence with SEC
20 Nov 15
UPLOAD
Letter from SEC
10 Nov 15
EFFECT
Notice of effectiveness
5 Aug 15
Ownership
SC 13G/A
PFM Health Sciences, LP
16 Feb 21
SC 13G/A
BlackRock Inc.
9 Mar 20
4
Jason Raleigh Nunn
24 Feb 20
4
ANDREW GUGGENHIME
24 Feb 20
4
MARK MCDADE
24 Feb 20
4
Matthew K Fust
24 Feb 20
4
Lori Lyons-Williams
24 Feb 20
4
Daljit Singh Aurora
24 Feb 20
4
Christopher Horan
24 Feb 20
4
EUGENE A BAUER
24 Feb 20